. Unique Merits of AIMP2 Targeting Anticancer Drugs
1. Previously Unexplored Target with Novel Working Mechanisms
(Global Initiatives in R&D and IP Position)
2. Generation of Tumorigenic Variant of AIMP2 Is Major Cause for Lung Caner
(Cancer-specific Target Available)
3. Suppression of AIMP2-DX2 Proven Effective against Lung Cancer
4. Small Chemical and siRNA Drug Candidates Are Available
5. Patents for Material and Usage Are Established Worldwide
. Our Products to develop
• Si-DX2 therapy -
– Specific AIMP2-DX2 inhibitor
– Aerosol inhalation administration
– Low toxicity and high efficiency of delivery
• Diagnostics
– Immuno histochemical Method
– QPCR AIMP2DX2 detection
– RISH detection system
– AIMP2 targeting small chemical drugs
– 4 drug candidates identified
Animal efficacy show
AIMP2 Patent Portfolio:
|
Country |
Patent or Patent Application Title |
Patent or Patent Application Number |
|
United States |
Method for treating cancer using p38/JTV-1 and method for screening pharmaceutical composition for treating cancer |
US 2004/0175375 10/463,676 18 Jun 03
|
|
Europe |
Medical use of p38/JTV-1 |
EP 1454628 09 Sep 03 |
|
Japan |
Pharmaceutical composition for cancer therapy with p38/JTV-1 as active ingredient and method for screening the composition |
JP 2003-377932 07 Nov. 2003
|
|
Korea |
Pharmaceutical composition for treatment of cancer containing p38/JTV-1 as effective component and screening method of pharmaceutical composition for treatment of cancer |
KR 2003-18424 25th Mar 2003
|
AIMP2-DX2 Patent Portfolio:
|
Country |
Patent Application Title |
Patent Application Number |
|
Korea |
Use of AIMP2-DX2 for the diagnosis and treatment of cancer |
KR10-2005-0110946 18th March, 2005 |
|
Korea |
Use of AIMP2-DX2 for the diagnosis and treatment of cancer |
KR10-2006-0047831 26th May, 2006 |
|
International (PCT) |
Use of AIMP2-DX2 for the diagnosis and treatment of cancer |
PCT/KR2005/003924 18th March, 2005 |
|
United States |
AIMP2-DX2 and its uses |
US 11/264,725 1st Nov. 2005 |
|
Europe |
AIMP2-DX2 and its uses |
EP05819055.4 4th April, 2007 |
|
China |
AIMP2-DX2 and its uses |
CN200580037802.9 30th April, 2007 |
|
Japan |
AIMP2-DX2 and its uses |
JP2007-542907 24th May, 2007 |
1. Overseas Licensing Opportunity
2. Seeking potential corporate partners
Yong U Kim
Researcher
Technology Business Center
KHIDI, provides various services on technology transfer. KHIDI will license and commercialise several technologies of KHIDI's client companies via collaboration with overseas partners.
View profile© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
